Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Cardiology

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Big bigCover of Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

More books from Springer US

bigCover of the book Trust and the Health of Organizations by

bigCover of the book Congestive Heart Failure by

bigCover of the book Ultrastructure of Skeletal Tissues by

bigCover of the book Broadband Infrastructure by

bigCover of the book Neurotransmitter Actions in the Vertebrate Nervous System by

bigCover of the book Medical and Nutritional Complications of Alcoholism by

bigCover of the book Formation of Visual Images by

bigCover of the book Promoting Nonviolence in Early Adolescence by

bigCover of the book Craft Production and Social Change in Northern China by

bigCover of the book Diagnosis and Treatment of Genitourinary Malignancies by

bigCover of the book Device Applications of Silicon Nanocrystals and Nanostructures by

bigCover of the book Computerized Basin Analysis by

bigCover of the book In Vitro Fertilization and Embryo Transfer by

bigCover of the book Field-Programmable Analog Arrays by

bigCover of the book Family Diversity and Family Policy: Strengthening Families for America’s Children by

We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy